Sanofi SA to Act as Orexigen Therapeutics, Inc.'s Contract Manufacturer for Contrave Outside North America

Wednesday, 6 Nov 2013 04:31pm EST 

Orexigen Therapeutics, Inc. (Orexigen), a biopharmaceutical company focused on the treatment of obesity, announced that it has entered into a commercial supply agreement with Sanofi SA to act as Orexigen's contract manufacturer for Contrave for territories outside North America. Sanofi SA will manufacture Contrave tablets at one of its several facilities in France. 

Company Quote

24 Dec 2014